Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
Saved in:
| Title: | Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? |
|---|---|
| Authors: | Messner DA; Donna A. Messner, PhD, Center for Medical Technology Policy, 401 E. Pratt Street, Suite 631, Baltimore, MD 21202, Tel: 410.547.2686 x101, Fax: 410.547.5088, Email: donna.messner@cmtpnet.org., Rabins P, Downing AC, Irizarry M, Foster NL, Al Naber J, Dabbous O, Fillit H, Gabler S, Krakauer R, Lotz D, Payzant E, Schneider L, Tyrone J, Van Amerongen D, Wuest D |
| Source: | The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2019; Vol. 6 (1), pp. 20-26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30569082 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Messner+DA%22">Messner DA</searchLink>; Donna A. Messner, PhD, Center for Medical Technology Policy, 401 E. Pratt Street, Suite 631, Baltimore, MD 21202, Tel: 410.547.2686 x101, Fax: 410.547.5088, Email: donna.messner@cmtpnet.org.<br /><searchLink fieldCode="AU" term="%22Rabins+P%22">Rabins P</searchLink><br /><searchLink fieldCode="AU" term="%22Downing+AC%22">Downing AC</searchLink><br /><searchLink fieldCode="AU" term="%22Irizarry+M%22">Irizarry M</searchLink><br /><searchLink fieldCode="AU" term="%22Foster+NL%22">Foster NL</searchLink><br /><searchLink fieldCode="AU" term="%22Al+Naber+J%22">Al Naber J</searchLink><br /><searchLink fieldCode="AU" term="%22Dabbous+O%22">Dabbous O</searchLink><br /><searchLink fieldCode="AU" term="%22Fillit+H%22">Fillit H</searchLink><br /><searchLink fieldCode="AU" term="%22Gabler+S%22">Gabler S</searchLink><br /><searchLink fieldCode="AU" term="%22Krakauer+R%22">Krakauer R</searchLink><br /><searchLink fieldCode="AU" term="%22Lotz+D%22">Lotz D</searchLink><br /><searchLink fieldCode="AU" term="%22Payzant+E%22">Payzant E</searchLink><br /><searchLink fieldCode="AU" term="%22Schneider+L%22">Schneider L</searchLink><br /><searchLink fieldCode="AU" term="%22Tyrone+J%22">Tyrone J</searchLink><br /><searchLink fieldCode="AU" term="%22Van+Amerongen+D%22">Van Amerongen D</searchLink><br /><searchLink fieldCode="AU" term="%22Wuest+D%22">Wuest D</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2019; Vol. 6 (1), pp. 20-26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30569082 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.14283/jpad.2018.42 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 20 Titles: – TitleFull: Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Messner DA – PersonEntity: Name: NameFull: Rabins P – PersonEntity: Name: NameFull: Downing AC – PersonEntity: Name: NameFull: Irizarry M – PersonEntity: Name: NameFull: Foster NL – PersonEntity: Name: NameFull: Al Naber J – PersonEntity: Name: NameFull: Dabbous O – PersonEntity: Name: NameFull: Fillit H – PersonEntity: Name: NameFull: Gabler S – PersonEntity: Name: NameFull: Krakauer R – PersonEntity: Name: NameFull: Lotz D – PersonEntity: Name: NameFull: Payzant E – PersonEntity: Name: NameFull: Schneider L – PersonEntity: Name: NameFull: Tyrone J – PersonEntity: Name: NameFull: Van Amerongen D – PersonEntity: Name: NameFull: Wuest D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2019 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2426-0266 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: The journal of prevention of Alzheimer's disease Type: main |
| ResultId | 1 |
